the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

New terminal at Sultan Ismail Petra Airport begins operations today

KOTA BHARU: The first phase of the new terminal at the Sultan Ismail Petra Airport (LTSIP) in Pengkalan Chepa, here, began operations today.

Malaysia Airports Holdings Berhad (MAHB) senior general manager Kamaruzzaman Razali said that the new terminal is expected to receive 30 to 35 flights and see an increase of 4,000 to 4,500 passengers a day.

“The work to upgrade the LTSIP terminal is progressing well and is expected to be fully completed by 2027,” he told reporters after inspecting the operations of the new LTSIP terminal today.

Kamaruzzaman said the upgraded facilities at LTSIP include an increased number of aerobridges compared to the old terminal, which had only three, along with a dedicated route for international passengers.

In addition, he said the new terminal is equipped with over 20 flight counters, an elevated car park, a dedicated taxi driver route, a fire and rescue station, a larger apron area, and a cashless operating system for the convenience of passengers.

Meanwhile, Kamaruzzaman said MAHB is currently in talks with relevant parties to facilitate flights from Singapore, Thailand, and Indonesia to LTSIP.

He said that the new LTSIP terminal has not been classified as an international airport as it has not scheduled any international flights and must fulfil several criteria.

The RM440 million LTSIP expansion and upgrading project aims to enhance facilities and increase the airport terminal’s capacity from 1.5 million to four million passengers per year.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings